Referenser

  1. Linde M, Stovner LJ, Zwart JA, Hagen K. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia. 2011;31(5):585-96.

  2. Nilsson Remahl I. LM, E. W. Huvudvärk, kraniella neuralgier och ansiktssmärtor. In: Nyholm D. BJ, editor. Neurologi. 6 ed. Stockholm: Liber AB; 2020. p. 179-99.

  3. Nationellt kliniskt kunskapsstöd. Migrän - Riktlinje 1177 för vårdpersonal: Sveriges regioner; 2022.

  4. Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, et al. Aids to management of headache disorders in primary care (2nd edition) : on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain. 2019;20(1):57.

  5. Verhagen AP, Damen L, Berger MY, Passchier J, Koes BW. Behavioral treatments of chronic tension-type headache in adults: are they beneficial? CNS Neurosci Ther. 2009;15(2):183-205.

  6. Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Shin BC, et al. Acupuncture for the prevention of tension-type headache. Cochrane Database Syst Rev. 2016;4(4):Cd007587.

  7. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011;31(9):1015-22.

  8. Varkey E. LM. Migrän. In: Dohrn I-M, Jansson E, Börjesson M, Hagströmer M, editors. FYSS 2021 : fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling. Stockholm: Läkartidningen förlag AB; 2021.

  9. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968-81.

  10. Kirthi V, Derry S, Moore RA, McQuay HJ. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010(4):Cd008041.

  11. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;2013(4):Cd008040.

  12. Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;2013(4):Cd008039.

  13. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668-75.

  14. Linde M, Elam M, Lundblad L, Olausson H, Dahlöf CG. Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia. Cephalalgia. 2004;24(12):1057-66.

  15. Janusmed. Sumatriptan: Region Stockholm;  [2025-06-13].

  16. Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2014;34(7):523-32.

  17. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;2013(6):Cd010610.

  18. Stubberud A, Flaaen NM, McCrory DC, Pedersen SA, Linde M. Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis. Pain. 2019;160(4):762-72.

  19. Bussone G, Rapoport A. Acute and preventive treatment of cluster headache and other trigeminal autonomic cephalgias. Handb Clin Neurol. 2010;97:431-42.

  20. Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2018;17(1):75-83.

  21. Lund NLT, Petersen AS, Fronczek R, Tfelt-Hansen J, Belin AC, Meisingset T, et al. Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments-a consensus article. J Headache Pain. 2023;24(1):121.

  22. Membrilla JA, Roa J, Díaz-de-Terán J. Preventive treatment of refractory chronic cluster headache: systematic review and meta-analysis. J Neurol. 2023;270(2):689-710.

  23. Obermann M, Nägel S, Ose C, Sonuc N, Scherag A, Storch P, et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol. 2021;20(1):29-37.

  24. Chowdhury D, Kordcal SR, Nagane R, Duggal A. ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache. Cephalalgia. 2024;44(10):33310‍24241‍291597.

  25. Rozen TD. Indomethacin-responsive TACs (paroxysmal hemicrania, hemicrania continua, and LASH): further proof of a distinct spectrum of headache disorders. Headache. 2013;53(9):1499-500.

  26. Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010;12(6):379-89.

  27. Bonfert M, Straube A, Schroeder AS, Reilich P, Ebinger F, Heinen F. Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache. Neuropediatrics. 2013;44(1):3-19.

  28. Hjalte F, Olofsson S, Persson U, Linde M. Burden and costs of migraine in a Swedish defined patient population - a questionnaire-based study. J Headache Pain. 2019;20(1):65.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida